301 people charged in massive $900 million false billings Medicare fraud Posted on June 22, 2016 by henrykotula Posted in Uncategorized Tagged ACA, Antikickback, DOJ, Fraud and Abuse, Fraud Related Crimes, HHS, Medicare Fraud, Medicare Part D Leave a comment http://www.healthcarefinancenews.com/news/301-people-charged-massive-900-million-false-billings-medicare-fraud More than 60 of the defendants arrested are charged with fraud related to the Medicare prescription drug benefit program known as Part D. Share this: Share on X (Opens in new window) X Share on Facebook (Opens in new window) Facebook Share on LinkedIn (Opens in new window) LinkedIn Like Loading...
Insulin prices have skyrocketed, putting drug makers on the defensive Posted on April 9, 2016 by henrykotula Posted in Uncategorized Tagged AMA, CDC, Diabetes Care Management, Health Policy, Insulin, Medicare Part D, Pharmaceutical Industry, Prescription Drug Costs, Public Health Leave a comment Insulin prices have skyrocketed, putting drug makers on the defensive Share this: Share on X (Opens in new window) X Share on Facebook (Opens in new window) Facebook Share on LinkedIn (Opens in new window) LinkedIn Like Loading...
CMS’ final 2017 Medicare Advantage rates lower than expected Posted on April 5, 2016 by henrykotula Posted in Uncategorized Tagged ACA, Capitation Rates, CMS, Health System, Hospital, Medicare Advantage, Medicare Part D Leave a comment http://www.healthcaredive.com/news/cms-final-2017-medicare-advantage-rates-lower-than-expected/416809/ Share this: Share on X (Opens in new window) X Share on Facebook (Opens in new window) Facebook Share on LinkedIn (Opens in new window) LinkedIn Like Loading...
Medicare Part D’s Importance Extends Far Beyond The Drug Benefit It Provides Posted on January 16, 2016 by henrykotula Posted in Uncategorized Tagged CMS, Health Policy, Medicare, Medicare Part D, Prescription Drug Benefits Leave a comment http://healthaffairs.org/blog/2016/01/15/medicare-part-ds-importance-extends-far-beyond-the-drug-benefit-it-provides/ Share this: Share on X (Opens in new window) X Share on Facebook (Opens in new window) Facebook Share on LinkedIn (Opens in new window) LinkedIn Like Loading...